跳至主要内容
临床试验/IRCT20221016056204N1
IRCT20221016056204N1已完成Unknown

The effectiveness of applying Mobile-Health Technology to manage modifiable risk factors of coronary artery disease for secondary prevention: a randomized clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 1,544 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
入组人数
1,544

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 75 years(—)
性别
All

入选标准

  • History of CAD defined as history of myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft surgery, coronary angiography confirming stenosis>50% in at least one of the major epicardial coronary arteries or their main branches.
  • Having at least one uncontrolled risk factor including: uncontrolled hypertension, uncontrolled dyslipidemia and current cigarette smoking for =12 months.
  • Aged between 25 to 75 years
  • Inclination to staying in study for two years
  • Having and ability of using smart phone by the participant or one of his/her trustworthy relatives who lives near him/her
  • Willing to control the risk factors using App
  • Provides informed consent to participate in the study

排除标准

  • Mental retardation
  • Individuals with prohibitive morbidity that requires close face-to-face monitoring.
  • End stage chronic disease such as: hepatic and/or renal failure, heart failure, active cancer

研究者

相似试验

Effect of M-Health on secondary prevention of... | 临床试验